Delay in treating age-related macular degeneration in Spain is associated with progressive vision loss
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Purpose To assess the impact on visual acuity of delays between diagnosis and treatment in patients with subfoveal neovascular age-related macular degeneration (NV-AMD) and to evaluate NV-AMD patients' emotional status before therapy initiation. Methods This retrospective, multicenter, epidemiological study included newly diagnosed NV-AMD patients registered in the Spanish national health system and referred to regional health centers for evaluation/treatment by a retinal specialist from 09/2005 to 03/2006. Records were reviewed and data abstracted at referring physicians' offices (diagnosis visit) and regional health centers (treatment visit). Treatment was at physicians' discretion. The Hospital Anxiety and Depression Scale was administered at the treatment visit (before therapy). Results Median time from the diagnosis to treatment visit was 2.3 months (95% confidence interval: 0.2-10.8 months). Vision loss had progressed at the treatment visit with a doubling in the percentage of patients with a visual acuity of 20/400 or worse (from 12.4 to 24.7%). The decrease in visual acuity from the diagnosis to the treatment visit was highly statistically significant (P Conclusions Delayed treatment of patients newly diagnosed with NV-AMD is associated with substantial visual acuity loss.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similar delay in access to services has been recorded in Canada, 67 Spain 68 and Germany.69,70”
From Defining response to anti-VEGF therapies in neovascular AMD (2015) · cites this paper as [68]
Citations
Cites
Pegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337
(1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.10.1329 · Cited by 2,192
Age-Related Macular Degeneration and Blindness due to Neovascular Maculopathy
Ferris, F. L., Fine, S. L., & Hyman, L. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040031330019 · Cited by 1,093
Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies
Ambati, J., Ambati, B. K., Yoo, S. H., Ianchulev, S., & Adamis, A. P. (2003) · Survey of Ophthalmology · doi:10.1016/s0039-6257(03)00030-4 · Cited by 959
The Prevalence of Age-related Maculopathy in the Rotterdam Study
Vingerling, J. R., Dielemans, I., Hofman, A., Grobbee, D. E., Hijmering, M., Kramer, C. F. L., & de Jong, P. T. V. M. (1995) · Ophthalmology · doi:10.1016/s0161-6420(95)31034-2 · Cited by 815
Brody, B. L., Gamst, A. C., Williams, R. A., Smith, A. R., Lau, P. W., Dolnak, D., Rapaport, M. H., Kaplan, R. M., & Brown, S. I. (2001) · Ophthalmology · doi:10.1016/s0161-6420(01)00754-0 · Cited by 581
(1991) · Archives of Ophthalmology · doi:10.1001/archopht.1991.01080090044025 · Cited by 495
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · Cited by 474
The Psychosocial Impact of Macular Degeneration
Williams, R. A. (1998) · Archives of Ophthalmology · doi:10.1001/archopht.116.4.514 · Cited by 423
Incidence and progression rates of age-related maculopathy: the Rotterdam Study.
Klaver, C. C. W., Assink, J. J. M., van Leeuwen, R., Wolfs, R. C. W., Vingerling, J. R., Stijnen, T., Hofman, A., & de Jong, P. T. (2001) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 353
Cited by
Clinically applicable deep learning for diagnosis and referral in retinal disease
De Fauw, J., Ledsam, J. R., Romera-Paredes, B., Nikolov, S., Tomasev, N., Blackwell, S., Askham, H., Glorot, X., O’Donoghue, B., Visentin, D., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0107-6 · Cited by 2,639
Defining response to anti-VEGF therapies in neovascular AMD
Amoaku, W. M., Chakravarthy, U., Gale, R., Gavin, M., Ghanchi, F., Gibson, J., Harding, S., Johnston, R. L., Kelly, S., Lotery, A., et al. (2015) · Eye · doi:10.1038/eye.2015.48 · Cited by 355
Mitchell, P., Korobelnik, J.-F., Lanzetta, P., Holz, F. G., Prunte, C., Schmidt-Erfurth, U., Tano, Y., & Wolf, S. (2010) · British Journal of Ophthalmology · doi:10.1136/bjo.2009.159160 · Cited by 295
Lim, J. H., Wickremasinghe, S. S., Xie, J., Chauhan, D. S., Baird, P. N., Robman, L. D., Hageman, G., & Guymer, R. H. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2011.09.013 · Cited by 141
Jiménez-Gómez, Y., Alba-Molina, D., Blanco-Blanco, M., Pérez-Fajardo, L., Reyes-Ortega, F., Ortega-Llamas, L., Villalba-González, M., Fernández-Choquet de Isla, I., Pugliese, F., Stoikow, I., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071473 · Cited by 19
Metadata
- Authors
- Arias, L., Armadá, F., Donate, J., García-Arumí, J., Giralt, J., Pazos, B., Piñero, A., Martínez, F., Mondéjar, J. J., Ortega, I., Zlateva, G., & Buggage, R.
- Affiliations
- Bellvitge University Hospital (ES)
- Hospital Universitario La Paz (ES)
- Universitat Autònoma de Barcelona (ES)
- Hospital Universitario de Valme (ES)
- Marqués de Valdecilla University Hospital (ES)
- Pfizer (United States) (US)
- Corresponding author
- Arias, L
- Venue
- Eye
- Published
- 2008-01-18
- Volume
- 23
- Issue
- 2
- Pages
- 326-333
- ISSN
- 0078-5334 (ISSN-L)
- 0950-222X
- 1476-5454
- OpenAlex
- W2024615783
- Cited by
- 67
- References
- 23
- Citations by year
- 2026: 2 · 2025: 4 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 4 · 2018: 2 · 2017: 6 · 2016: 4 · 2015: 3 · 2014: 4 · 2013: 12 · 2012: 2
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Eye (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- neovascular age-related macular degeneration, treatment delay, time from diagnosis to treatment, visual acuity loss, depression, anxiety, emotional state, lesion size
- MeSH terms
- Aged, Aged, 80 and over, Anxiety, Depression, Female, Humans, Macular Degeneration, Male, Retrospective Studies, Time Factors, Vision Disorders, Visual Acuity, Treatment Outcome, Disease Progression, Choroidal Neovascularization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Delay in treating age-related macular degeneration in Spain is associated with progressive vision loss. https://app.cochat.ai/papers/10.1038/sj.eye.6703053
- The paper
- Arias, L., Armadá, F., Donate, J., García-Arumí, J., Giralt, J., Pazos, B., Piñero, A., Martínez, F., Mondéjar, J. J., Ortega, I., Zlateva, G., & Buggage, R. (2009). Delay in treating age-related macular degeneration in Spain is associated with progressive vision loss. Eye. https://doi.org/10.1038/sj.eye.6703053
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.